title: Comment to Letter to the Editor regarding the article by R. Casciaro et al. titled 'Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: case report and review of literature'.
authors.forename: Rosaria
authors.initials: R
authors.lastname: Casciaro
authors.forename: Federico
authors.initials: F
authors.lastname: Cresta
authors.forename: Aldo
authors.initials: A
authors.lastname: Naselli
authors.forename: Elio
authors.initials: E
authors.lastname: Castagnola
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000188:drug therapy*; D001232:Aspergillus fumigatus / Q000187:drug effects*; D003550:Cystic Fibrosis / Q000150:complications*; D006801:Humans; D008297:Male
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B